Package inserts overstate diagnostic TB tests' accuracy

July 17, 2012, American Society for Microbiology

Clinicians and laboratory professionals often rely on manufacturers' package inserts to assess the accuracy of diagnostic medical tests. However, package inserts frequently greatly overstate such tests' accuracy, according to a case study of package inserts for tuberculosis (TB), which is published in the July 2012 Journal of Clinical Microbiology.

"It is likely that these issues are not restricted to TB, and they should be explored for diagnostics for other diseases as well," says first author Claudia M. Denkinger of Beth Israel Deaconess Medical Center, Boston, MA.

The study grew out of an understanding that the market for TB tests includes many diagnostics which have not been recommended by independent organizations such as the (WHO) and the (FDA).

"These diagnostics have significant market share in much of the world where the market is not regulated, notably in developing nations, despite questionable performance," says Denkinger. "Given that oftentimes end-users have only the package insert to assess a test, we wondered how well package inserts actually reflected a tests performance."

In the study, Denkinger et al. compared package inserts' evaluations to systematic reviews of 19 diagnostic tests. The package inserts tended to overrate tests' accuracies by 20-30 percent as compared with systematic reviews of their performance, although within the package inserts, tests that were recommended by independent organizations were likely to report more realistic performance. "Our study suggests that independent assessments of diagnostic tests are helpful to provide reliable data to decision-makers and clinicians on the performance of ," says Denkinger.

"We propose that countries create systems for in-country validation of TB tests or that international organizations such as the WHO expand their evaluation programs in order to help countries procure quality-assured TB tests."

Such studies "must go beyond accuracy and assess clinical impact of tests on decision-making and patient outcomes and collect operational and cost-effectiveness data in programmatic settings," conclude the investigators, who were led by Madhukar Pai of McGill University, Montreal, Canada.

Explore further: Serological antibody tests to detect active tuberculosis are inaccurate and not cost-effective

More information: C.M. Denkinger, J. Grenier, J. Minion, and M. Pai, 2012. Promise versus reality: optimism bias in package inserts for tuberculosis diagnostics. J. Clin. Microbiol. 50:2455-2461. DOI:10.1128/JCM.00842-12

Related Stories

Serological antibody tests to detect active tuberculosis are inaccurate and not cost-effective

August 9, 2011
Despite being widely available for sale in low-and-middle income countries, commercial serological tests used to detect active tuberculosis (by identifying antibodies to the tuberculosis-causing bacterium in a blood sample) ...

WHO calls for ban on 'unreliable' TB blood tests

July 20, 2011
The World Health Organisation warned on Wednesday that millions of blood tests conducted every year to diagnose tuberculosis are unreliable and putting patients' lives in danger.

WHO: Blood tests for tuberculosis are unreliable

July 18, 2011
(AP) -- Widely used blood tests to detect tuberculosis are "dangerous" to patients because they are unreliable and can produce wrong results, the World Health Organization warned Sunday.

New TB drug-resistance test shows promise but needs investment for those diagnosed to be cured

July 26, 2011
Two research studies in this week's PLoS Medicine suggest that a new automated DNA test for tuberculosis (Xpert MTB/RIF), which can detect TB within 2 hours and has been endorsed by the World Health Organization, can significantly ...

Blood tests for active TB not accurate or cost-effective

August 10, 2011
Commercial blood serum antibody tests—widely used in India and other developing countries to diagnose active tuberculosis—are not accurate or cost-effective, according to an analysis by researchers at the Johns ...

Recommended for you

Nanoparticle vaccine offers universal protection against influenza A viruses, study finds

January 24, 2018
Researchers have developed a universal vaccine to combat influenza A viruses that produces long-lasting immunity in mice and protects them against the limitations of seasonal flu vaccines, according to a study led by Georgia ...

Leprosy's drug resistance and origin revealed by genome analysis

January 24, 2018
Leprosy is an infectious disease with gruesome symptoms. It damages the skin, peripheral nerves, the upper respiratory tract, and the eyes. Despite being curable with multidrug therapy, leprosy still persists in many developing ...

A new theory on reducing cardiovascular disease risk in binge drinkers

January 23, 2018
A new study shows that binge drinkers have increased levels of a biomarker molecule—microRNA-21—that may contribute to poor vascular function.

Flu infection study increases understanding of natural immunity

January 23, 2018
People with higher levels of antibodies against the stem portion of the influenza virus hemagglutinin (HA) protein have less viral shedding when they get the flu, but do not have fewer or less severe signs of illness, according ...

New long-acting approach for malaria therapy developed

January 22, 2018
A new study, published in Nature Communications, conducted by the University of Liverpool and the Johns Hopkins University School of Medicine highlights a new 'long acting' medicine for the prevention of malaria.

Virus shown to be likely cause of mystery polio-like illness

January 22, 2018
A major review by UNSW researchers has identified strong evidence that a virus called Enterovirus D68 is the cause of a mystery polio-like illness that has paralysed children in the US, Canada and Europe.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.